Jin Su

500 total citations
28 papers, 399 citations indexed

About

Jin Su is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Jin Su has authored 28 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Pharmacology. Recurrent topics in Jin Su's work include Traditional Chinese Medicine Analysis (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Jin Su is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Jin Su collaborates with scholars based in China, United States and Canada. Jin Su's co-authors include Hongjun Yang, Haiyu Xu, Qianqian Cao, Zhentao Zhang, Qi Qi, Yueyue Chen, Jiaxu Chen, Wei Yao, Song Lin and Kenji Hashimoto and has published in prestigious journals such as Genetics, Journal of Pharmacology and Experimental Therapeutics and Medicine.

In The Last Decade

Jin Su

27 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Su China 12 165 64 55 47 46 28 399
Anoop Kishore India 13 154 0.9× 43 0.7× 50 0.9× 52 1.1× 28 0.6× 52 494
Lina Liang China 14 222 1.3× 92 1.4× 52 0.9× 61 1.3× 29 0.6× 31 483
Mei Ling Jin South Korea 12 297 1.8× 56 0.9× 53 1.0× 55 1.2× 25 0.5× 12 571
Jianhui Rong Hong Kong 13 233 1.4× 39 0.6× 70 1.3× 34 0.7× 26 0.6× 21 518
En Hu China 15 315 1.9× 63 1.0× 72 1.3× 26 0.6× 29 0.6× 39 623
Rania M. Salama Egypt 13 198 1.2× 35 0.5× 37 0.7× 57 1.2× 17 0.4× 25 492
Caner Günaydın Türkiye 11 168 1.0× 36 0.6× 32 0.6× 99 2.1× 24 0.5× 26 519
Rashita Makkar India 11 142 0.9× 25 0.4× 44 0.8× 65 1.4× 20 0.4× 20 427
Xingui Xiong China 14 295 1.8× 110 1.7× 96 1.7× 50 1.1× 17 0.4× 26 577
Changxiang Li China 14 213 1.3× 66 1.0× 61 1.1× 63 1.3× 16 0.3× 32 521

Countries citing papers authored by Jin Su

Since Specialization
Citations

This map shows the geographic impact of Jin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Su more than expected).

Fields of papers citing papers by Jin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Su. The network helps show where Jin Su may publish in the future.

Co-authorship network of co-authors of Jin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Su. A scholar is included among the top collaborators of Jin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Su. Jin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Jin, et al.. (2024). Effectiveness and safety of Qianjinweijing decoction in the treatment of bronchiectasis: A systematic review and meta-analysis. European Journal of Integrative Medicine. 72. 102418–102418.
2.
Johnston, Tom H., Alix M.B. Lacoste, Paula Ravenscroft, et al.. (2024). Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia. Neuropharmacology. 248. 109880–109880. 3 indexed citations
3.
Xu, Xiaoling, et al.. (2023). Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. Journal of Nanobiotechnology. 21(1). 105–105. 25 indexed citations
4.
Wu, Dan, Ping Wang, Chunhui Zhao, et al.. (2023). Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis. Phytomedicine. 121. 155075–155075. 18 indexed citations
5.
Li, Shuang, et al.. (2022). Supermolecules as a quality markers of herbal medicinal products. Heliyon. 8(12). e12497–e12497. 6 indexed citations
6.
Li, Shuang, Jin Su, Wei Cai, & Jianxin Liu. (2021). Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment. Frontiers in Pharmacology. 12. 699245–699245. 25 indexed citations
7.
Yao, Wei, Song Lin, Jin Su, et al.. (2021). Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents. Translational Psychiatry. 11(1). 140–140. 84 indexed citations
8.
9.
Zhang, Yu, et al.. (2020). Molecular imaging of atherosclerotic plaque with lipid nanobubbles as targeted ultrasound contrast agents. Colloids and Surfaces B Biointerfaces. 189. 110861–110861. 23 indexed citations
10.
Ma, Xiaolei, Tingting Zhang, Zhigang Luo, et al.. (2020). Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe() mice. Acta Pharmaceutica Sinica B. 10(9). 1769–1783. 33 indexed citations
11.
Guo, Feifei, Wen Zhang, Jin Su, Haiyu Xu, & Hongjun Yang. (2019). Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network. Frontiers in Pharmacology. 10. 49–49. 18 indexed citations
12.
Howson, Patrick A., Tom H. Johnston, Paula Ravenscroft, et al.. (2019). Beneficial Effects of Trehalose on Striatal Dopaminergic Deficits in Rodent and Primate Models of Synucleinopathy in Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 369(3). 364–374. 21 indexed citations
13.
Li, Junfang, Jin Su, Xuefeng Xiao, et al.. (2018). Identification of quality markers of Yuanhu Zhitong tablets based on integrative pharmacology and data mining. Phytomedicine. 44. 212–219. 38 indexed citations
14.
Wang, Ping, Shihuan Tang, Jin Su, et al.. (2018). [Modern research progress of traditional Chinese medicine based on integrative pharmacology].. PubMed. 43(7). 1297–1302. 5 indexed citations
15.
16.
Su, Jin, Shihuan Tang, Feifei Guo, et al.. (2018). [Compatibility law of Baizhi formulae and molecular mechanism of core herbal pair "Baizhi-Chuanxiong"].. PubMed. 43(7). 1331–1337. 3 indexed citations
17.
Xu, Haiyu, Zhenming Liu, Yanqiong Zhang, et al.. (2017). [Exploiture and application of an internet-based Computation Platform for Integrative Pharmacology of Traditional Chinese Medicine].. PubMed. 42(18). 3633–3638. 21 indexed citations
18.
Zhan, Dongsheng, et al.. (2013). Research on properties of small molecule peptides mixture fermented by industrial starter culture in different ratio.. Zhongguo rupin gongye. 41(3). 4–24. 1 indexed citations
19.
Su, Jin, et al.. (1993). Possibility of targeting treatment for ischemic heart disease with liposome (I).. PubMed. 36(5). 590–16. 9 indexed citations
20.
Su, Jin, L. Belmont, & Robert A. Sclafani. (1990). Genetic and molecular analysis of the SOE1 gene: a tRNA(3Glu) missense suppressor of yeast cdc8 mutations.. Genetics. 124(3). 523–531. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anoop Kishore Breakdown of academic impact, for papers by Lina Liang Breakdown of academic impact, for papers by Mei Ling Jin Breakdown of academic impact, for papers by Jianhui Rong Breakdown of academic impact, for papers by En Hu Breakdown of academic impact, for papers by Rania M. Salama Breakdown of academic impact, for papers by Caner Günaydın Breakdown of academic impact, for papers by Rashita Makkar Breakdown of academic impact, for papers by Xingui Xiong Breakdown of academic impact, for papers by Changxiang Li
Rankless by CCL
2026